How it went
Did it last?
- 1 of 3 said the benefit wore off.
- 1 of 3 needed to keep doing it to stay well.
Read from what people wrote. A story that ends without a follow-up counts as lasting, so treat these as minimums.
| Outcome described | Accounts | Share |
|---|---|---|
| Full recovery | 0 | 0% |
| Near-full | 0 | 0% |
| Substantial | 3 | 100% |
| Partial | 0 | 0% |
| Relapsed | 0 | 0% |
| No benefit | 0 | 0% |
Only 3 accounts. Treat these percentages as anecdotes, not rates.
By how ill people were
| Severity at worst | How it went | n | Recovered |
|---|---|---|---|
| Moderate | 1 | 0% | |
| Severe | 1 | 0% |
1 accounts don’t say how ill the person was.
Who published these accounts
67% of these accounts are on pages that sell this treatment or a program around it. Those pages publish their successes; compare the independent row.
All 3 accounts
-
Recovery Protocol Cheat Sheet
Christy's posted recovery protocol lists an extensive regimen: pre-protocol, three months of Eliquis 5 mg daily and clopidogrel 75 mg daily; from February 2024 a "foundation" of nutritional antivirals including matcha green tea, coconut oil, unpasteurized…
-
Inspiritol: A New Investigational Drug for ME/CFS and Long COVID
Inspiritol, an investigational supplement, was used for 2 to 5 months by two unnamed long-COVID patients (evaluated alongside a third ME/CFS patient), though the page gives no specific dose or protocol. Researchers reported "dramatic improvement" in these…
-
ATP working well for me
After COVID worsened his decades-old condition, Keshav began sublingual ATP and reports dramatic improvement within 3 days, and within 24 hours of his first injectable ATP dose felt his "mind was much sharper," mood and energy much better. Follow-up posts…